These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15255263)

  • 21. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
    Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis.
    Turner BJ; Lopes EC; Cheema SS
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):171-6. PubMed ID: 14527871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
    Brooks KJ; Hill MD; Hockings PD; Reid DG
    NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.
    Garbuzova-Davis S; Willing AE; Milliken M; Saporta S; Zigova T; Cahill DW; Sanberg PR
    Exp Neurol; 2002 Apr; 174(2):169-80. PubMed ID: 11922659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
    Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
    Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice.
    Snow RJ; Turnbull J; da Silva S; Jiang F; Tarnopolsky MA
    Neuroscience; 2003; 119(3):661-7. PubMed ID: 12809687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
    J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
    Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1
    Koza LA; Winter AN; Holsopple J; Baybayon-Grandgeorge AN; Pena C; Olson JR; Mazzarino RC; Patterson D; Linseman DA
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32570926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
    Fontanilla CV; Wei X; Zhao L; Johnstone B; Pascuzzi RM; Farlow MR; Du Y
    Neuroscience; 2012 Mar; 205():185-93. PubMed ID: 22206942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis.
    Nagano I; Ilieva H; Shiote M; Murakami T; Yokoyama M; Shoji M; Abe K
    J Neurol Sci; 2005 Aug; 235(1-2):61-8. PubMed ID: 15990113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
    Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis.
    Xu Z; Chen S; Li X; Luo G; Li L; Le W
    Neurochem Res; 2006 Oct; 31(10):1263-9. PubMed ID: 17021948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
    Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis.
    Evans MC; Gaillard PJ; de Boer M; Appeldoorn C; Dorland R; Sibson NR; Turner MR; Anthony DC; Stolp HB
    Acta Neuropathol Commun; 2014 Jun; 2():66. PubMed ID: 24923195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin does not preserve motor neurons in a mouse model of familial ALS.
    Grignaschi G; Zennaro E; Tortarolo M; Calvaresi N; Bendotti C
    Amyotroph Lateral Scler; 2007 Feb; 8(1):31-5. PubMed ID: 17364433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal nitric oxide synthase (nNOS) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene.
    Sasaki S; Warita H; Abe K; Iwata M
    Acta Neuropathol; 2002 May; 103(5):421-7. PubMed ID: 11935256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.